LivaNova PLC (LIVN) Financials
LIVN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.6 billion | 1.3 billion |
| March 31, 2026 | 2.5 billion | 1.3 billion |
| Dec. 31, 2025 | 2.6 billion | 1.4 billion |
| Sept. 30, 2025 | 2.6 billion | 1.4 billion |
LIVN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 35.0 million | 16.9 million |
| March 31, 2026 | 926000 | 8.3 million |
| Dec. 31, 2025 | 50.2 million | 9.4 million |
| Sept. 30, 2025 | 62.2 million | 9.9 million |
LIVN Net Income
No data available :(
LIVN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 516.6 million | 289.9 million | 58.5 million |
| March 31, 2026 | 539.7 million | 331.9 million | 55.7 million |
| Dec. 31, 2025 | 635.6 million | 393.5 million | 48.3 million |
| Sept. 30, 2025 | 646.1 million | 349.0 million | 52.1 million |
LIVN Shares Outstanding
LIVN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 31.6 million | 53.7 million | 158.1 million | - |
| March 31, 2026 | 14.3 million | 49.1 million | 143.6 million | - |
| Dec. 31, 2025 | 32.2 million | 52.1 million | 143.4 million | - |
| Sept. 30, 2025 | 22.9 million | 48.6 million | 138.5 million | - |
LIVN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 390.6 million | 116.9 million |
| March 31, 2026 | 362.3 million | 117.4 million |
| Dec. 31, 2025 | 360.9 million | 121.1 million |
| Sept. 30, 2025 | 357.8 million | 112.9 million |
LIVN Revenue by Segment
Graph available only for paid members. Upgrade to see it.
LIVN
Price: $76.55
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.39 USD
P/E Ratio: 22.56
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United Kingdom
Volume: 315000
Ebitda: 55.0 millionMarket Capitalization: 4.1 billion